New Pancreatic Cancer Drug ONC-392 Shows Early Promise in Trials
“`html New Pancreatic Cancer Drug Shows Promise in Early Clinical Trials Researchers have reported encouraging results from early-stage clinical trials of a novel pancreatic cancer treatment, offering new hope in a disease notorious for its resistance to conventional therapies. The experimental drug, known as ONC-392, targets a specific immune pathway to help the body’s defenses…